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on an extensive literature review, this is only the fifth pediat-
ric patient with a primary intramedullary aGG and the sec-
ond with documented progression-free survival of over 4 
years. Another 4 primary intramedullary aGGs in adults and 
7 patients with spinal dissemination from a cerebral aGG or 
malignant transformation of a low-grade GG have been re-
ported. In comparison to the published case reports, which 
often indicate significant neurological dysfunction and rath-
er short survival, the neurological recovery in this patient 
was favorable, and the oncologic outcome even more so. 
This is an argument for the use of the aggressive treatment 
regimen of complete resection followed by radio- and che-
motherapy applied here. 
 
Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Gangliogliomas (GGs) are a rather rare entity among 
the primary central nervous system neoplasms and ac-
count for 1% of all central nervous system tumors and 
approximately 4% of pediatric central nervous system tu-
mors  [1] . They show a biphasic morphologic pattern of 
either a predominant neuronal phenotype or else promi-
nent glial elements  [2] . The anaplastic variant (WHO 
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 Abstract 
 Gangliogliomas (GGs) are a small subset of intramedullary 
spinal cord tumors in children. The anaplastic variant (WHO 
grade III) appears to be an extreme rarity. A literature re-
search revealed only 15 case reports of intramedullary ana-
plastic GGs (aGGs) and only 4 pediatric patients. The course 
of an 18-month-old boy with sudden onset of paraparesis is 
presented. Spinal MRI revealed a contrast-enhancing intra-
medullary tumor ranging from T6 to T12. The patient under-
went a standard laminectomy/laminoplasty and gross total 
resection of the lesion. His neurological status remained un-
changed postoperatively and he recovered very well during 
outpatient neurorehabilitation. Neuropathologic examina-
tion revealed an aGG of WHO grade III. Because of the high-
grade histology, adjuvant radiotherapy and chemotherapy 
with temozolomide were administered. The patient subse-
quently recovered to a normal functional status. Clinical and 
radiographic progression-free survival is now 4 years. Based 
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grade III) is encountered only very rarely – about 5% of 
all GGs are anaplastic – and predominantly affects pa-
tients in their late twenties  [3] . Anaplastic GGs (aGGs) 
have areas of pronounced hypercellularity, vascular pro-
liferations, necrosis and many mitotic figures, especially 
in their glial component  [4] . Only 15 case reports exist of 
aGGs occurring in the spinal cord, 5 of them as a result 
of spinal dissemination of a cerebral aGG (metastatic spi-
nal aGG) and 2 with histological and cytogenetic evi-
dence of malignant transformation of a former low-grade 
GG (secondary spinal aGG). Of the remaining 8 primary 
spinal cord aGGs, only 4 were reported in pediatric pa-
tients  [1, 3–12] .
 We present the course of an 18-month-old boy who 
was diagnosed with a primary intramedullary aGG rang-
ing from T6 to T12. The treatment approach is delineated 
and discussed.
 Case Report 
 Clinical Features and Surgery 
 A boy of 18 months with normal prior development was eval-
uated with a recent history of repeated episodes of frequent falls 
and walking difficulties. Clinical examination revealed a signif-
icant paraparesis. MRI of the spine showed a contrast-enhancing 
mass lesion ranging from T6 to T12 ( fig. 1 , panel 1). Initially, a 
typical low-grade tumor was suspected and complete surgical re-
section was recommended. Prior to surgery, the patient could not 
walk and could stand only briefly with a caregiver’s support. 
Babinski’s sign was positive bilaterally. A standard laminotomy/
laminoplasty from T6 to T12 was performed and a gross total re-
section of the tumor achieved, with intraoperative neurophysi-
ologic documentation of functionally intact motor pathways. 
Postoperative neurologic status remained unchanged, and post-
operative recovery was uneventful. During outpatient neurore-
habilitation, the patient recovered very well and has achieved a 
normal functional status and a practically normal subsequent 
motor development allowing all activities, including sports (i.e. 
skiing).
 Neuroimaging Findings 
 Figure 1 shows serial MRIs from before surgery to the most 
recent scan 4 years after diagnosis. Early postoperative imaging 
demonstrated the gross total resection ( fig. 1 , panel 2b). Follow-up 
imaging of the thoracic spine shows no evidence of tumor recur-
rence and no significant spinal deformity.
 Histological Features 
 Histological examination revealed a moderately cellular glio-
neuronal neoplasm with glomeruloid proliferation of small-cali-
ber blood vessels and focal zones of necrosis. The tumor was pre-
dominantly composed of atypical glial cells with moderate nucle-
ar pleomorphism. Several mitotic figures could be demonstrated. 
An apparent biphasic growth pattern was not present, but some 
loosely distributed so-called dysplastic ganglion cells were ob-
served ( fig.  2 , arrow). Structures typical for a long-standing or 
slow-growing process (Rosenthal fibers or eosinophilic granular 
bodies) were not encountered.
 Fig. 1. Serial MRI of the patient’s thoracic 
spine. Panel 1: preoperative situation (T1 
with contrast); panel 2: postoperative situ-
ation (2a: T1 with contrast; 2b: subtraction 
imaging, T1 with contrast minus T1 na-
tive); panel 3: situation at 1 month (T1 with 
contrast); panel 4: situation at 4 months, 
after completion of radiotherapy (T1 with 
contrast); panel 5: situation at 9 months 
(T1 with contrast); panel 6: situation at 1 
year (T1 with contrast); panel 7: situation 
at 2 years (T1 with contrast); panel 8: situ-
ation at 3 years (T1 with contrast); panel 9: 
situation at 4 years (T1 with contrast). 
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 Immunohistochemical examination confirmed the glial na-
ture of the tumor (positive glial fibrillary acidic protein stain of 
the spindle-shaped and ganglioid cellular elements). Staining for 
synaptophysin and CD34 identified the neuronal component. In 
addition, CD34 identified some so-called satellite cells. The Ki-67 
proliferative index was approximately 10%.
 Taken together, the following features warranted the diagnosis 
of an aGG (WHO grade III): mitotic activity and vascular prolif-
eration in the context of focal necrosis in a glioneuronal tumor 
with nuclear atypia.
 Conclusive histological diagnosis was provided by the Insti-
tute for Neuropathology at the University Hospital of Zurich and 
reconfirmed by the Brain Tumor Reference Center in Bonn.
 Treatment Protocol and Outcome 
 In the face of a highly unusual histological diagnosis, adjuvant 
treatment was discussed extensively. After an aggressive and suc-
cessful resection, an aggressive curative treatment plan with ra-
diotherapy and temozolomide chemotherapy was devised. The 
patient received percutaneous radiotherapy from T4 to T10 in 26 
fractions of 1.8 Gy, resulting in a treatment dose of 46.8 Gy and 
an additional cumulative diagnostic radiation dose of 4 Gy, add-
ing up to a total radiation dose of 50.8 Gy to the spine. Concomi-
tant administration of temozolomide (75 mg/m 2 /day) had to be 
interrupted after 17 days because of leukopenia, but was rein-
stalled 6 weeks later at a dose of 200 mg/m 2 (days 1–5, 23 days off, 
total of 18 cycles). The medication was then tolerated well under 
symptomatic treatment of the side effects. The patient remained 
in a good condition and without tumor recurrence. The patient’s 
growth developed according to the 50th percentile; clinically, a 
discreet kyphosis without scoliosis in the functional position and 
a slight difference in the length of the legs (1.5 cm) was noted. 
Progression-free follow-up is now 4 years. 
 Discussion 
 Anaplastic primary intramedullary spinal cord GGs 
are extremely rare. An extensive literature research re-
vealed only 4 more pediatric and 4 adult patients ( table 1 ).
 The clinical presentation and the imaging studies in 
the present patient, as well as those in the literature, differ 
little from the experience with children with more com-
mon spinal cord tumors. This patient had presented with 
a history of motor regression and subsequent significant 
paraparesis, which is a common finding for spinal cord 
tumors in children  [13] . MRI showed an enhancing intra-
medullary tumor appearing much like the frequently 
seen pilocytic astrocytoma  [13] . At surgery, the tumor 
again appeared rather like the common low-grade tumor 
found in children, and complete removal was not more or 
less difficult than in such cases.
 However, neuropathologic examination revealed a GG 
with unusual features indicating a higher grade and ful-
filling the criteria for an anaplastic variant (WHO III). 
The absence of findings in favor of a pilocytic astrocy-
toma, like Rosenthal fibers or eosinophilic granular bod-
ies, in combination with mitotic activity, vascular prolif-
eration and focal necrosis are strong arguments in favor 
of an anaplastic process  [4] .
 This surprising finding resulted in extensive discus-
sions about the further treatment plan. Usually, complete 
resection of low-grade tumors in children results in a fa-
vorable long-term oncologic outcome  [14] and a favorable 
neurologic outcome when motor pathways remain intact 
 [15] . However, the few anecdotal precedents of this rare 
tumor variant provided some evidence for an unfavor-
able outcome with surgical resection followed by either 
radio- or chemotherapy  [1, 4–9] . There is only one report 
of a long-term survivor in the pediatric population ( ta-
ble 1 , gray shading), and this patient received combined 
adjuvant radiochemotherapy treatment  [4] . Therefore, 
combined treatment with percutaneous irradiation and 
adjuvant concomitant chemotherapy with temozolomide 
was planned based on this case report and some prior 
evidence concerning treatment of low- and high-grade 
spinal cord astrocytomas  [4, 16, 17] .
 The patient’s further neurologic outcome was favor-
able with a practically complete neurologic recovery, as 
evidenced by normal physical activities. Oncologic out-
come was equally favorable, with a 4-year clinical and 
radiographic progression-free survival, and thus this case 
differs from most prior reports ( table 1 ).
 Four other case reports of pediatric primary spinal 
aGG were found in the literature, as follows: one compa-
 Fig. 2. Standard hematoxylin-eosin stain of the resection speci-
men ( ! 200). Arrow: dysplastic ganglion cell. Left half of the im-
age: glomeruloid vascular proliferation. 
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rable to the patient presented here with stable disease at 
61 months after diagnosis but no information about her 
clinical status ( table 1 , gray shading)  [4] ; one patient with 
postoperative right leg palsy and a progression-free fol-
low-up of 22 months  [9] ; one with progressive disease 
after 7 months  [4] , and one without information regard-
ing outcome (high-grade tumor in a series of cerebral 
and spinal low-grade GGs that was not further dis-
cussed)  [11] . In adult patients, 4 descriptions of primary 
intramedullary aGG were found  [5, 6, 10, 12] . Spinal dis-
semination of a primary cerebral aGG or malignant 
transformation of a low-grade GG to aGG was described 
in 7 patients, including adults and children ( table 1 )  [1, 3, 
7, 8] .
 Karremann et al.  [4] report one pediatric patient with 
stable disease at 61 months, a clinical course comparable 
to that of the patient reported here. After gross total re-
section of the tumor, this long-term survivor also re-
ceived a combination of radio- and chemotherapy. Un-
fortunately, the authors give no information about the 
clinical status of this patient  [4] .
 The other patient in the series of Karremann et al.  [4] 
had a less favorable outcome. Gross total resection was 
achieved, and adjuvant chemotherapy was given but no 
radiotherapy. Leptomeningeal dissemination was diag-
nosed in this patient 1 month after surgery, and clinical 
progression occurred at 7 months  [4] .
 Karabekir et al.  [9] describe a partial tumor resection 
with postoperative right leg weakness in their patient. Ra-
diotherapy of 40 Gy was given, and stable disease (resid-
ual tumor) with a persistent neurological deficit were 
documented 22 months postoperatively  [9] .
 Lang et al.  [11] report a series of GGs, cerebral and spi-
nal, but give no specific description of the course of their 
single patient with primary spinal aGG. Their recom-
mendation is to perform best possible surgery with close 
clinical follow-up, keeping radio- or chemotherapy as an 
option for recurrence. However, these data date back over 
20 years, and the recommendation for observation refers 
mainly to the low-grade GGs  [11] .
 In 3 of the 4 case descriptions of primary spinal aGG 
in adult patients, the outcome was fatal due to tumor-
related complications  [5, 6, 10] . The fourth adult patient 
suffered from fragile X syndrome and primary aGG. 
There is no information available on the clinical course 
of this patient  [12] .
 Spinal metastasis of a primary cerebral aGG is report-
ed in 5 cases. Blümcke et al.  [3] found spinal manifesta-
tions in 22% of their patients diagnosed with aGG, while 
Nakajima et al.  [1] give a description of a patient with an 
unfavorable clinical course after spinal leptomeningeal 
spread of a cerebral aGG 3 months after diagnosis.
 An interesting feature of GG is described by Di Patre 
et al.  [7] and Jay et al.  [8] . In their patients, a primary low-
grade GG seemed to undergo malignant transformation 
or show evidence of malignancy in its clinical behavior. 
The patient reported by Di Patre et al.  [7] suffered a high-
grade local recurrence of an initially low-grade spinal GG 
with severe neurologic impairment after the second op-
eration. Jay et al.  [8] give a description of a cerebral GG 
without evidence of malignancy in the histologic features 
of 3 consecutive tissue samples (2 cranial, 1 spinal). De-
spite that finding, spinal metastasis was diagnosed 2 
years after the initial operation. Cytogenetic evaluation 
of the tissue showed an unusual karyotype of this low-
grade GG. The patient received chemotherapy after the 
third operation and remained progression free for 5 
months  [8] .
 Conclusion 
 The neurosurgical concept of complete resection of an 
intramedullary spinal cord tumor with best possible 
functional preservation is valid also in the context of pri-
mary spinal aGG. This approach, in combination with 
aggressive adjuvant treatment with both radio- and che-
motherapy, was oncologically and neurologically suc-
cessful in our patient, now with 4 years of progression-
free follow-up. Considering the extreme rarity of intra-
medullary aGG, this anecdotal report may serve as a 
blueprint for others confronted with the same therapeu-
tic choices and challenges.
 Acknowledgement 
 The authors thank Ianina Scheer, MD, for performing the pa-
tient’s neuroimaging.
 
 References  1 Nakajima M, Kidooka M, Nakasu S: Ana-
plastic ganglioglioma with dissemination to 
the spinal cord: a case report. Surg Neurol 
1998; 49: 445–448. 
 2 Luyken C, Blumcke I, Fimmers R, Urbach H, 
Wiestler OD, Schramm J: Supratentorial 
gangliogliomas: histopathologic grading 
and tumor recurrence in 184 patients with a 
median follow-up of 8 years. Cancer 2004; 
 101: 146–155. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
6/
9/
20
16
 4
:2
5:
03
 P
M
 Spinal Anaplastic Ganglioglioma Pediatr Neurosurg 2012;48:42–47 47
 3 Blümcke I, Wiestler OD: Gangliogliomas: an 
intriguing tumor entity associated with focal 
epilepsies. J Neuropathol Exp Neurol 2002; 
 61: 575–584. 
 4 Karremann M, Pietsch T, Janssen G, Kramm 
CM, Wolff JE: Anaplastic ganglioglioma in 
children. J Neurooncol 2009; 92: 157–163. 
 5 Bevilacqua G, Sarnelli R: Ganglioglioma of 
the spinal cord. A case with a long survival. 
Acta Neuropathol 1979; 48: 239–242. 
 6 Chrétien F, Djindjian M, Caramelle P, Ricol-
fi F, Christov C: A 42-year-old man with a 
densely vascular spinal mass. Brain Pathol 
2007; 17: 119–121. 
 7 Di Patre PL, Payer M, Brunea M, Delavelle J, 
De Tribolet N, Pizzolato G: Malignant trans-
formation of a spinal cord ganglioglioma – 
case report and review of the literature. Clin 
Neuropathol 2004; 23: 298–303. 
 8 Jay V, Squire J, Blaser S, Hoffman HJ, Hwang 
P: Intracranial and spinal metastases from a 
ganglioglioma with unusual cytogenetic ab-
normalities in a patient with complex partial 
seizures. Childs Nerv Syst 1997; 13: 550–555. 
 9 Karabekir HS, Balci C, Tokyol C: Primary 
spinal anaplastic ganglioglioma. Pediatr 
Neurosurg 2006; 42: 374–378. 
 10 Kitano M, Takayama S, Nagao T, Yoshimura 
O: Malignant ganglioglioma of the spinal 
cord. Acta Pathol Jpn 1987; 37: 1009–1018. 
 11 Lang FF, Epstein FJ, Ransohoff J, Allen JC, 
Wisoff J, Abbott IR, Miller DC: Central ner-
vous system gangliogliomas. 2. Clinical out-
come. J Neurosurg 1993; 79: 867–873. 
 12 Rodewald L, Miller DC, Sciorra L, Barabas 
G, Lee ML: Central nervous system neo-
plasm in a young man with Martin-Bell syn-
drome – fra(X)-XLMR. Am J Med Genet 
1987; 26: 7–12. 
 13 Constantini S, Houten J, Miller DC, Freed D, 
Ozek MM, Rorke LB, Allen JC, Epstein FJ: 
Intramedullary spinal cord tumors in chil-
dren under the age of 3 years. J Neurosurg 
1996; 85: 1036–1043. 
 14 Constantini S, Miller DC, Allen JC, Rorke 
LB, Freed D, Epstein FJ: Radical excision of 
intramedullary spinal cord tumors: surgical 
morbidity and long-term follow-up evalua-
tion in 164 children and young adults. J Neu-
rosurg 2000; 93: 183–193. 
 15 Kothbauer KF, Deletis V, Epstein FJ: Motor-
evoked potential monitoring for intramed-
ullary spinal cord tumor surgery: correlation 
of clinical and neurophysiological data in a 
series of 100 consecutive procedures. Neuro-
surg Focus 1998; 4:e1. 
 16 McGirt MJ, Goldstein IM, Chaichana KL, 
Tobias ME, Kothbauer KF, Jallo GI: Extent of 
surgical resection of malignant astrocyto-
mas of the spinal cord: outcome analysis of 
35 patients. Neurosurgery 2008; 63: 55–60. 
 17 Kim WH, Yoon SH, Kim CY, Kim KJ, Lee 
MM, Choe G, Kim IA, Kim JH, Kim YJ, Kim 
HJ: Temozolomide for malignant primary 
spinal cord glioma: an experience of six cas-
es and a literature review. J Neurooncol 2011; 
 101: 247–254. 
 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
6/
9/
20
16
 4
:2
5:
03
 P
M
